PFD report

David Edward Jackson · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 24 Oct 2017•West Sussex

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
3

Raised in this report

Recipients
2

Named on the report

Responses found
1

Of 2 recipients

Stated actions
2

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised3

  1. Failure to conduct timely and sufficiently informed medication reviews for long-term repeat prescriptions
    Part of recurring concern: Inadequate review of long-term medication usePart of recurring concern: Unreliable review and monitoring of repeat prescriptions
  2. Inadequate recording of medication reviews and reasons for repeat prescribing
    Part of recurring concern: Failure to reliably document the rationale for consequential decisionsPart of recurring concern: Inadequate recording of medication prescribing decisionsPart of recurring concern: Inadequate review of long-term medication usePart of recurring concern: Unreliable review and monitoring of repeat prescriptions
  3. Failure to establish and record arrangements for repeat prescription collection, delivery and pharmacy coordination
    Part of recurring concern: Unreliable prescription collection and delivery arrangements
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.1

  1. Action

    Refer controlled-drug prescribing and medication-review issues for national review and a decision on whether guidance requires amendment.

    Stated by NHS EnglandStated plannedThe respondent said that this action was planned when they made their response on 28 November 2017.

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.2

  1. Position

    Annual medication reviews were considered unlikely to have prevented this death, which resulted primarily from the patient's decision not to seek medical advice.

    Stated by NHS EnglandDisputes the concernThe respondent disagreed with part of the concern or the basis for it.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to conduct timely and sufficiently informed medication reviews for long-term repeat prescriptions

Wider context from the report

“Over the next 10 years, the records note a medication review was conducted by ████████ on 21 Oct 2008 and 2 March 2010 but on the records alone. There is one entry on the patient record for ████████ on 23 November 2015 noting only ‘medication review done’. When giving evidence, ████████ indicated that when ████████ retired in 2015 she took over Mr Jackson as a patient but she had never actually seen him. Her recollection was that she had conducted annual medication reviews by considering the patient's past history but only one is noted on the record printout. GMC good practice guidance was discussed with ████████ as follows: • Good medical practice (2013) – para 16: In providing clinical care you must prescribe drugs or treatment, including repeat prescriptions, only when you have adequate knowledge of the patient's health, and are satisfied that the drugs or treatment serve the patient's needs; and, • Prescribing and Managing Medicines (2013) – paragraphs 51; 54; 55; 56; 59 o 51: Whether you prescribe with repeats or on a oneoff basis, you must make sure that suitable arrangements are in place for monitoring, follow-up and review, taking account of the patients' needs and any risks arising from the medicines. o 54: Pharmacists can help improve safety, efficacy and adherence in medicines use, for example by advising patients about their medicines and carrying out medicines reviews. This does not relieve you of your duty to ensure that your prescribing and medicines management is appropriate… o 55: You are responsible for any prescription you sign, including repeat prescriptions for medicines initiated by colleagues, so you must make sure that any repeat prescription you sign is safe and appropriate. You should consider the benefits of prescribing with repeats to reduce the need for repeat prescribing. o 56: As with any prescription, you should agree with the patient what medicines are appropriate and how their condition will be managed, including a date for review. You should make clear why regular reviews are important and explain to the patient what they should do if they: a) suffer side effects or adverse reactions, or b) stop taking the medicines before the agreed review date (or a set number of repeats have been issued), You must make clear records of these discussions and your reasons for repeat prescribing. o 59: When you issue repeat prescriptions or prescribe with repeats, you should make sure that procedures are in place to monitor whether the medicine is still safe and necessary for the patient. You should keep a record of dispensers who hold original repeat dispensing prescriptions so that you can contact them if necessary. 1. When asked about current practice in relation to issuing prescriptions for drugs such as Soneryl or Co-dydramol ████████ acknowledged national guidance had tightened up particularly in respect of issuing prescriptions to patients for opiate based drugs. She accepted that medical thinking had moved on considerably. She was candid and accepted that in respect of Mr Jackson he had not been seen for 10 years and must have fallen through the cracks in terms of medication reviews including a period when the surgery had a shortage of doctors. This suggests a need to review: a. how and when medication reviews are carried out in the Fitzalan Medical Group; b. a potential training need for group doctors in GMC good practice; or, c. the development of a local CCG/Group policy. ”

Is this part of a recurring concern?

Yes — Inadequate review of long-term medication use; Unreliable review and monitoring of repeat prescriptions.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Inadequate recording of medication reviews and reasons for repeat prescribing

Wider context from the report

“Over the next 10 years, the records note a medication review was conducted by ████████ on 21 Oct 2008 and 2 March 2010 but on the records alone. There is one entry on the patient record for ████████ on 23 November 2015 noting only ‘medication review done’. When giving evidence, ████████ indicated that when ████████ retired in 2015 she took over Mr Jackson as a patient but she had never actually seen him. Her recollection was that she had conducted annual medication reviews by considering the patient's past history but only one is noted on the record printout. GMC good practice guidance was discussed with ████████ as follows: • Good medical practice (2013) – para 16: In providing clinical care you must prescribe drugs or treatment, including repeat prescriptions, only when you have adequate knowledge of the patient's health, and are satisfied that the drugs or treatment serve the patient's needs; and, • Prescribing and Managing Medicines (2013) – paragraphs 51; 54; 55; 56; 59 o 51: Whether you prescribe with repeats or on a oneoff basis, you must make sure that suitable arrangements are in place for monitoring, follow-up and review, taking account of the patients' needs and any risks arising from the medicines. o 54: Pharmacists can help improve safety, efficacy and adherence in medicines use, for example by advising patients about their medicines and carrying out medicines reviews. This does not relieve you of your duty to ensure that your prescribing and medicines management is appropriate… o 55: You are responsible for any prescription you sign, including repeat prescriptions for medicines initiated by colleagues, so you must make sure that any repeat prescription you sign is safe and appropriate. You should consider the benefits of prescribing with repeats to reduce the need for repeat prescribing. o 56: As with any prescription, you should agree with the patient what medicines are appropriate and how their condition will be managed, including a date for review. You should make clear why regular reviews are important and explain to the patient what they should do if they: a) suffer side effects or adverse reactions, or b) stop taking the medicines before the agreed review date (or a set number of repeats have been issued), You must make clear records of these discussions and your reasons for repeat prescribing. o 59: When you issue repeat prescriptions or prescribe with repeats, you should make sure that procedures are in place to monitor whether the medicine is still safe and necessary for the patient. You should keep a record of dispensers who hold original repeat dispensing prescriptions so that you can contact them if necessary. 1. When asked about current practice in relation to issuing prescriptions for drugs such as Soneryl or Co-dydramol ████████ acknowledged national guidance had tightened up particularly in respect of issuing prescriptions to patients for opiate based drugs. She accepted that medical thinking had moved on considerably. She was candid and accepted that in respect of Mr Jackson he had not been seen for 10 years and must have fallen through the cracks in terms of medication reviews including a period when the surgery had a shortage of doctors. This suggests a need to review: a. how and when medication reviews are carried out in the Fitzalan Medical Group; b. a potential training need for group doctors in GMC good practice; or, c. the development of a local CCG/Group policy. ”

Is this part of a recurring concern?

Yes — Failure to reliably document the rationale for consequential decisions; Inadequate recording of medication prescribing decisions; Inadequate review of long-term medication use; Unreliable review and monitoring of repeat prescriptions.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to establish and record arrangements for repeat prescription collection, delivery and pharmacy coordination

Wider context from the report

“2. ████████ was also asked how were repeat prescriptions requested, collected or delivered. She was unable to help me in Mr Jackson's case but referred to a potential patient advocate, I believe meaning the person who nominated to collect his prescription. In this case for some time that was ████████ but given her increasing immobility this may have been a neighbour. ████████ also referred to working with local pharmacists but the details are unclear. This again suggests a need to review: a. the period of time that Mr Jackson remained on repeat prescriptions without being seen; b. the unknown arrangements for collection or delivery; and, c. possibly the arrangements with local pharmacies. ”

Is this part of a recurring concern?

Yes — Unreliable prescription collection and delivery arrangements.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Refer controlled-drug prescribing and medication-review issues for national review and a decision on whether guidance requires amendment.

Verbatim wording from the response

“NHS England acknowledges that the issues highlighted in this case may represent a future risk to patient safety within primary care at large. NHS England will refer the arising issues, particularly with regard to the suitability of current guidelines for the issuing of Controlled Drugs prescriptions, to NHS England’s national prescribing team for a decision upon whether or not current guidance needs to be amended. Should you require an update on this, I can report back to you by the end of summer 2018.”

Source location

2017-0308-Response-by-NHS-England
Page 5 · response
Published 28 November 2017

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Annual medication reviews were considered unlikely to have prevented this death, which resulted primarily from the patient's decision not to seek medical advice.

Verbatim wording from the response

“e) The passing of Mr Jackson was not related to the prescriptions of either barbiturates or co-dydramol. The associated finding of hypertension and ischaemic heart disease had not been identified clinically nor had symptoms been reported by the patient. Even if face to face medication reviews had been undertaken annually it is”

Source location

2017-0308-Response-by-NHS-England
Page 3 · response
Published 28 November 2017

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The national prescribing team will decide whether guidance on controlled-drug prescriptions requires amendment.

Verbatim wording from the response

“National actions”

Source location

2017-0308-Response-by-NHS-England
Page 5 · response
Published 28 November 2017

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.1

  1. 1

    Provide input to a CQC inspection focused on prescribing.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 28 November 2017.

Recipient positions A position is what a recipient says about a concern when they do not describe a specific action.1

  1. 1

    The barbiturate and co-dydramol prescriptions were considered reasonable and safe, and were not linked to the death.

    Stated by NHS EnglandDisputes the concernThe respondent disagreed with part of the concern or the basis for it.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Provide input to a CQC inspection focused on prescribing.

Verbatim wording from the response

“9. NHS England provided input to a CQC inspection with a focus on prescribing scheduled for Tuesday 19th of December 2017.”

Source location

2017-0308-Response-by-NHS-England
Page 5 · response
Published 28 November 2017

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The barbiturate and co-dydramol prescriptions were considered reasonable and safe, and were not linked to the death.

Verbatim wording from the response

“c) With further reference to the specific medication Mr Jackson was prescribed, very few patients are now prescribed barbiturates for insomnia. This medicine had been prescribed for 45 years or more. During the 1970s and 1980s this was a commonly used medication to treat this condition. A consultation with Dr McLeod on the 18th of October 2007 records a consultation which notes that other medication (more commonly prescribed benzodiazepines) had been offered but were not favoured by the patient. Under this circumstance, the continuation of this medicine was reasonable and safe. There is no suggestion that barbiturates were linked to the cause of death.”

Source location

2017-0308-Response-by-NHS-England
Page 3 · response
Published 28 November 2017

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
1/2

Data last updated 7 September 2026